MANAGEMENT OF RECURRENT AND OR METASTATIC DISEASE

MANAGEMENT OF RECURRENT AND/OR METASTATIC DISEASE

Patients with a low burden of disease or oligometastatic deposit(s) and a satisfactory performance status can be o ff ered salvage surgery and/or radiotherapy with curative intent. Patients with are eligible for systemic treatment. Current standard of care options depend on previous exposure to platinum-containing c hemotherapy , but include both immunotherapy and palliative chemotherapy regimens. Nonetheless, the poor prognosis for these patients remains. - MANAGEMENT OF RECURRENT AND/OR METASTATIC DISEASE

Patients with a low burden of disease or oligometastatic deposit(s) and a satisfactory performance status can be o ff ered salvage surgery and/or radiotherapy with curative intent. Patients with are eligible for systemic treatment. Current standard of care options depend on previous exposure to platinum-containing c hemotherapy , but include both immunotherapy and palliative chemotherapy regimens. Nonetheless, the poor prognosis for these patients remains. -